Lamigan, Flordeliza E.
HRN: 11-37-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
CEFTRIAXONE 1G (VIAL)
07/16/2025
07/23/2025
IV DRIP
2g
Q24
UTI
Checking Initial Appropriateness